Please assess the completion status of the following clinical trial:

Trial Title: Comparative Effectiveness Trial of Communication Strategies in the Management of Chronic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Within a 90-day period prior to the patient recruitment date:~* ≥30 days of prescriptions for opioid medications; or~* 2 or more opioid prescriptions; or~* a total amount of ≥700 Morphine Milligram Equivalents (MME) in a single opioid prescription;~and~* Patients who have had 1 or more Cedars-Sinai Medical Group primary care physician in the year prior to the study start date; and~* At least 1 visit during the follow-up year (the follow-up year will start after they consent to be in the study).~Prescriptions in the inpatient setting will not make a patient eligible for this study.~Exclusion Criteria:~* Individuals less than 18 years of age; or~* Individuals with any cancer treatment (chemotherapy or radiotherapy) administered 180 days or less prior to patient recruitment; or~* Individuals with a cancer diagnosis in the Problem List 180 days or less prior to patient recruitment (patients with cancer surveillance only will be included in the study); or~* Individuals with palliative care treatment administered 180 days or less prior to patient recruitment; or~* Individuals with any end-of-life treatment (comfort care) prior to patient recruitment; or~* Patients currently taking prescription medications (e.g. Suboxone, subutex, Buprenex, Butrans, Probuphine, Belbuca, buprenorphine/naloxone, Zubsolv, and Bunavail) for Opioid Use or other Substance Use Disorder treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clinical Decision Support (Type: EXPERIMENTAL): Patients within the physicians randomized to the IDM arm will receive the Clinical Decision Support alerts via the EHR when certain order criteria are triggered appropriately.
- Patient Education and Activation Tools (Type: EXPERIMENTAL): Patients within the physicians randomized to SDM will receive the PEAT materials via REDCap two days prior to their PCP office visit. They will receive these materials every time they have an office visit with their PCP.

Based on this trial design, predict the completion outcome and termination type (if applicable).